The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit ...

The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug ...

The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...

The suit accuses the "Big Three" of steering diabetes patients toward high-priced insulin to benefit their bottom lines ...

“The FTC’s administrative action seeks to put an end to the Big Three PBMs’ exploitative conduct and marks an important step ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...

The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.

Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, ...

The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...